Evidence map›Paper›PMID 34679726›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Curcumin and Carnosic Acid Cooperate to Inhibit Proliferation and Alter Mitochondrial Function of Metastatic Prostate Cancer Cells.

Saniya Ossikbayeva, Marina Khanin, Yoav Sharoni, Aviram Trachtenberg, Sultan Tuleukhanov, Richard Sensenig, Slava Rom, Michael Danilenko, Zulfiya Orynbayeva

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Curcumin in treatment of hematological cancers: Promises and challenges.Journal of traditional and complementary medicine · 2024
    Review
  13. Review
  14. Review
  15. Review
  16. Redox-Active Molecules as Therapeutic Agents.Antioxidants (Basel, Switzerland) · 2022
    Article
  17. Cytotoxicity of Thioalkaloid-EnrichedPharmaceuticals (Basel, Switzerland) · 2022
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Saniya OssikbayevaDepartment of Surgery, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Marina KhaninDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva 8410501, Israel.
Yoav SharoniDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva 8410501, Israel.ORCID 0000-0002-1898-1666
Aviram TrachtenbergDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva 8410501, Israel.ORCID 0000-0003-2030-1786
Sultan TuleukhanovDepartment of Biophysics and Biomedicine, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
Richard SensenigDepartment of Surgery, Cooper University Hospital, Camden, NJ 08103, USA.
Slava RomDepartment of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.ORCID 0000-0002-1050-1955
Michael DanilenkoDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva 8410501, Israel.ORCID 0000-0001-9466-6169
Zulfiya OrynbayevaDepartment of Surgery, Drexel University College of Medicine, Philadelphia, PA 19102, USA.ORCID 0000-0002-7401-2165
Ben-Gurion University of the Negev · ILAl-Farabi Kazakh National University · KZCooper University Hospital · USDrexel University · USTemple University · US

Funding

Cornelius Beukenkamp EndowmentIsrael Science Foundation 226/16
6 · The paper itself

Abstract

Anticancer activities of plant polyphenols have been demonstrated in various models of neoplasia. However, evidence obtained in numerous in vitro studies indicates that proliferation arrest and/or killing of cancer cells require quite high micromolar concentrations of polyphenols that are difficult to reach in vivo and can also be (geno)toxic to at least some types of normal cells. The ability of certain polyphenols to synergize with one another at low concentrations can be used as a promising strategy to effectively treat human malignancies. We have recently reported that curcumin and carnosic acid applied at non-cytotoxic concentrations synergistically cooperate to induce massive apoptosis in acute myeloid leukemia cells, but not in normal hematopoietic and non-hematopoietic cells, via sustained cytosolic calcium overload. Here, we show that the two polyphenols can also synergistically suppress the growth of DU145 and PC-3 metastatic prostate cancer cell cultures. However, instead of cell killing, the combined treatment induced a marked inhibition of cell proliferation associated with G

Indexed as

carnosic acidcell cyclecurcuminOxPhosprostate cancerSGK1

Identifiers

PMID34679726
PMCPMC8533243
OpenAlexW3206208780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.